+Search query
-Structure paper
| Title | Molecular basis of antagonism of the dimeric human arginine vasopressin receptor 1A. |
|---|---|
| Journal, issue, pages | Nat Commun, Year 2026 |
| Publish date | Jan 16, 2026 |
Authors | Peiyu Zhong / Bingxin Chu / Zijing Yu / Yu Qiao / Yu Ding / Yongdeng Zhang / Xudong Wu / ![]() |
| PubMed Abstract | Arginine vasopressin (AVP) and oxytocin (OT) are peptide hormones critical for various physiological processes. Vasopressin receptor 1 A (V1aR), a primary AVP target, is promising for central ...Arginine vasopressin (AVP) and oxytocin (OT) are peptide hormones critical for various physiological processes. Vasopressin receptor 1 A (V1aR), a primary AVP target, is promising for central nervous system (CNS) disorders therapies, yet the mechanisms of antagonism and oligomerization remain poorly understood. Here, we present structures of human V1aR in its apo state and in complexes with antagonists: atosiban, balovaptan, and SRX246. Structural analyses reveal a dimeric V1aR assembly, validated by functional assays and imaging in cells. The apo structure shows a flat extracellular loop 2 (ECL2) with unpaired cysteines, undergoing significant conformational changes upon ligand binding. Antagonist-bound structures, combined with mutagenesis and radioligand binding assays, uncover distinct binding modes and key determinants for antagonism and selectivity. These findings provide a comprehensive understanding of V1aR assembly and dynamic regulation, offering valuable insights for structure-guided development of new antagonists targeting dimeric V1aR for CNS disorders. |
External links | Nat Commun / PubMed:41545407 |
| Methods | EM (single particle) |
| Resolution | 2.8 Å |
| Structure data | EMDB-64555, PDB-9uwi: |
| Chemicals | ![]() ChemComp-CLR: |
| Source |
|
Keywords | SIGNALING PROTEIN / GPCR / small molecule / antagonist / nanobody |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links


homo sapiens (human)
Keywords